Bioengineered human cardiac tissue constructs & 3D printed pharmaceuticals: Advancing patient specific models & therapies

Date & time: 2024-03-12 09:00:00

CET | 1:30 p.m. IST

Hosted by:

Dr Arunkumar Palaniappan, Assistant Professor, Vellore Institute of Technology

SPEAKER

Dr. Arunkumar Palaniappan

Assistant Professor,  Vellore Institute of Technology & Faculty In-charge for VIT’s 3D bioprinting facility called as “Human Organ Manufacturing Engineering (HOME)” Lab

12 Mar
2024
9:00 a.m. CET
1:30 p.m. IST

About the webinar

Join us for an insightful webinar where Dr. Arunkumar Palaniappan will delve into two critical applications of 3D bioprinting: building 3D cardiac tissue models and novel pharmaceutical formulations

Save your spot and learn about:

  • Bioengineering strategies used to construct an engineered cardiac tissue.
  • How 3D bioprinting surpasses traditional electrospinning methods.
  • The pivotal role of 3D printing technology in shaping novel pharmaceutical formulations.

About the speaker

Dr Arunkumar Palaniappan is an Assistant Professor with Centre for Biomaterials, Cellular and Molecular Theranostics (CBCMT), Vellore Institute of Technology, Vellore. He is also the Faculty In-charge for VIT’s 3D bioprinting facility called as “Human Organ Manufacturing Engineering (HOME)” Lab, which was established in 2019 with a collaborative effort between VIT and Shenzhen University, China.

He joined VIT Vellore in November 2019 after three years of post-doctoral research training at University of Cincinnati Medical Centre, Cincinnati, Ohio and The Ohio State University, Columbus, Ohio.

His research group is focussed on developing various biomaterials and nano-materials for therapy as well as sensing applications. One of the other primary research focuses of his group is to develop bioinks for 3D bioprinting applications, esp. towards 3D bioprinting of cardiac and cancer tissue mimics. He believes in human tissue/disease models for human medicines and working towards development of 3D human tissue models for drug screening applications.

He has successfully completed one DST-SERB project and currently runs three ICMR projects. He has 25 international peer-reviewed research publications to his credit, 4 book chapters, 1 US patent, and 4 Indian patents granted.

Save your spot!